We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+9.21%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$4.04B
AUM Growth
+$368M
Cap. Flow
+$68.3M
Cap. Flow %
1.69%
Top 10 Hldgs %
14.84%
Holding
1,360
New
108
Increased
584
Reduced
484
Closed
87

Sector Composition

Rank Sector Weight
1 Technology 14.02%
2 Healthcare 12.17%
3 Financials 11.29%
4 Consumer Discretionary 8.82%
5 Industrials 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NNC
1351
DELISTED
Nuveen North Carolina Quality Municipal Income Fund
NNC
-13,700
Closed -$185K
AREX
1352
DELISTED
Approach Resources Inc.
AREX
-217,997
Closed -$30K
VSM
1353
DELISTED
Versum Materials, Inc.
VSM
-7,949
Closed -$421K
TEUM
1354
DELISTED
Pareteum Corporation
TEUM
-45,435
Closed -$59K
WPG
1355
DELISTED
Washington Prime Group Inc.
WPG
-1,387
Closed -$52K
VIA
1356
DELISTED
Viacom Inc. Class A
VIA
-9,665
Closed -$254K
IBDK
1357
DELISTED
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
-10,217
Closed -$254K
CELG
1358
DELISTED
Celgene Corp
CELG
-65,713
Closed -$6.53M
DWIN
1359
DELISTED
Invesco DWA Tactical Multi-Asset Income ETF
DWIN
-25,709
Closed -$659K

Similar funds

Oppenheimer & Co's Q4 2019 Portfolio in Review

As of Q4 2019, Oppenheimer & Co held 1,360 positions worth $4.04B, up 10% from $3.67B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Oppenheimer & Co's Q4 2019 filing shows 108 new, 584 increased, 484 reduced and 87 closed positions. Its largest new stake was CAE Inc. Common Shares: 78,310 shares worth $2.07M. The largest sale was Celgene Corp, an estimated $6.53M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

  • Oppenheimer & Co's largest Q4 2019 buy was CAE Inc. Common Shares: 78,310 shares worth $2.07M.
  • Oppenheimer & Co added most to DocuSign in Q4 2019, an estimated $4.67M increase.
  • Oppenheimer & Co's biggest Q4 2019 reduction was Apple, cutting an estimated $5.68M.
  • Oppenheimer & Co fully exited Celgene Corp in Q4 2019, selling an estimated $6.53M.
  • Oppenheimer & Co's ten largest holdings make up 15% of its $4.04B portfolio in Q4 2019.
  • Oppenheimer & Co opened 108 new positions and closed 87 in Q4 2019.
  • Oppenheimer & Co's portfolio value rose 10% quarter-over-quarter to $4.04B.

Based on Oppenheimer & Co's 13F filing for Q4 2019, filed 7 Feb 2020.